Munafa Stock Market Course + Intraday & FNO calls 
VENUSREM_BE announcements Venus Remedies Limited announcements and dividends declared NSE
Venus Remedies Limited Complete list of announcements declared & dividend announcements by Venus Remedies Limited VENUSREM_BE
Venus Remedies Limited VENUSREM_BE listed on NSE and deals inAnnouncements and dividends declared by Venus Remedies Limited VENUSREM_BE
Venus Remedies gets new market authorisations for drugs in Vietnam
Pharma major Venus Remedies has received new marketing authorisations in Vietnam for its drugs Methotrexate, Cefuroxime, and Irinotecan. These approvals expand the company's presence in South Asia's growing pharmaceutical market. This marks 29 active produ
Announcement as on 09 November 2025
Venus Remedies gets GMP approval for pre-filled syringe facility
Indian pharmaceutical company Venus Remedies received a significant approval from the Malaysian authorities. The company's Baddi facility, equipped with advanced robotic technology, met the stringent quality standards for producing pre-filled syringes. Thi
Announcement as on 05 November 2024
Venus Remedies get market authorisations for two cancer drugs from Morocco, Philippines
Venus Remedies Ltd has received marketing authorisations for two key oncology drugs, carboplatin and bortezomib, from Morocco and the Philippines. These approvals are part of the company's strategy to expand its oncology range and meet the growing global d
Announcement as on 30 September 2024
Venus Remedies gets marketing authorisations for three cancer drugs from Ukraine
​​ Saransh Chaudhary, President, Global Critical Care, Venus Remedies, said, "These marketing approvals mark a significant milestone in our global expansion strategy. We are looking forward to introducing the entire range of our oncology products in Uk
Announcement as on 18 March 2024
Venus Remedies secures GMP approval from UNICEF
Venus Remedies announced that it has secured good manufacturing practices (GMP) approval from the United Nations Children's Fund (UNICEF) to supply Cephalosporin antibiotics for treating infections.
Announcement as on 11 March 2024
Announcements by Venus Remedies Limited first page | Next page |
VENUSREM_BE Venus Remedies Limited current price & indicator signals
Recent prices of VENUSREM_BE Venus Remedies Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 31 Wed Dec 2025 | 766.10 | 730.30 to 777.00 | 3.32% | 0.59 times |
| 30 Tue Dec 2025 | 741.50 | 730.00 to 759.00 | -2.51% | 0.56 times |
| 29 Mon Dec 2025 | 760.60 | 748.65 to 799.00 | -3.48% | 1.32 times |
| 26 Fri Dec 2025 | 788.05 | 783.00 to 815.00 | -1.7% | 1.2 times |
| 24 Wed Dec 2025 | 801.65 | 800.00 to 839.90 | -1.75% | 1.01 times |
| 23 Tue Dec 2025 | 815.95 | 807.00 to 830.00 | 1.33% | 0.88 times |
| 22 Mon Dec 2025 | 805.25 | 745.65 to 805.25 | 4.99% | 1.14 times |
| 19 Fri Dec 2025 | 766.95 | 730.50 to 774.00 | 2.66% | 0.55 times |
| 18 Thu Dec 2025 | 747.05 | 730.00 to 763.00 | -2.62% | 0.9 times |
| 17 Wed Dec 2025 | 767.15 | 758.00 to 799.00 | -2.73% | 0.97 times |
| 16 Tue Dec 2025 | 788.70 | 746.00 to 798.00 | 0.58% | 1.46 times |
| 15 Mon Dec 2025 | 784.15 | 784.15 to 823.00 | -5% | 1.84 times |
Videos related to: VENUSREM_BE announcements Venus Remedies Limited announcements and dividends declared NSE
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
